(CIDRAP News) – The influenza vaccine that was developed to fight the 2009 pandemic saved roughly 300 lives and prevented about 1 million illnesses and 6,000 hospitalizations, or under 3% of the estimated total burden in each category, according to new estimates from the Centers for Disease Control and Prevention (CDC).
(CIDRAP News) – Researchers following recent antiviral trends in the United States have found a troubling drop in the use of the drugs for treating hospitalized patients with lab-confirmed flu, especially children.
(CIDRAP News) A workshop summary released today by the Institute of Medicine (IOM) offers a wide range of observations and suggestions about what worked well and not so well during the pandemic H1N1 influenza vaccination campaigna complex, months-long operation with a cast of thousands.
(CIDRAP News) The US Centers for Disease Control and Prevention (CDC) recently issued new guidance for preventing flu in healthcare settings that reflects a year's worth of new information about the 2009 H1N1 virus and recommends surgical masks rather than N-95 respirators when providing routine care for flu patients.
(CIDRAP News) About 16 million remaining doses of monovalent 2009 H1N1 vaccine made by Sanofi Pasteur and packaged in multidose vials will expire sooner than expected, but expiration dates have not yet been determined, federal health officials and the company said today.